N03AX11 • topiramate • Nervous system | Antiepileptics | Other antiepileptics
Topiramate is an antiepileptic drug used in the treatment of epilepsy and migraines. It works through multiple mechanisms, including blocking sodium channels, enhancing GABA (gamma-aminobutyric acid) activity, and inhibiting glutamate receptors, thereby reducing neuronal excitability.
Topiramate is administered orally, usually twice daily, with the dose gradually adjusted to minimize the risk of side effects. It is indicated both as monotherapy and as adjunctive therapy in controlling seizures and preventing migraines.
Common side effects include drowsiness, dizziness, weight loss, memory disturbances, and tingling sensations in the extremities. In rare cases, severe adverse reactions such as metabolic acidosis, glaucoma, or kidney stone formation may occur. Regular monitoring of the patient's condition is essential during treatment.
Topiramate is an effective and well-tolerated therapeutic option for managing epilepsy and migraines, contributing to improved quality of life for patients.
Substance: topiramate
Date of last drug list: 01-01-2019
Commercial code: W55387015
Concentration: 25mg
Pharmaceutical form: tablets
Quantity: 30
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).